investment advisor

San Antonio, TX, based Investment company Trust Co buys JM Smucker Co, Eastman Chemical Co, iShares Core S&P Small-Cap, Western Digital, Vanguard Value ETF – DNQ, iShares Core U.S. Aggregate Bond, Exxon Mobil, Vanguard Intermediate-Termorate Bond ETF, Vanguard REIT ETF – DNQ, Vanguard Growth ETF – DNQ, sells Discover Financial Services, Time Warner, Exelon, The Home Depot, Spectra Energy during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Trust Co. As of 2017-03-31, Trust Co owns 311 stocks with a total value of $179 million. These are the details of the buys and sells.

New Purchases: SJM, ENB, SHM, VPU, HCN, VYM, YHOO, CTAS, FE, TD, Added Positions: EMN, IJR, WDC, QCOM, T, VTV, WFC, AGG, XOM, BLK, Reduced Positions: DFS, TWX, EXC, HD, FB, AAPL, JNJ, DKS, PCLN, MSFT, Sold Out: SE, VER, BIV, SDLP, PCI, CLMT, VOT, IXJ, JTD, VOO,

For the details of Trust Co’s stock buys and sells, go to

investment advisor: Cogentix Medical, Inc.(CGNT)

Advisors’ Opinion:

  • [By William Romov]

    AMSC has beaten analysts’ earnings expectations in eight of the last nine quarters, according to S&P Capital IQ.

    Penny Stocks to Buy for December 2017, No. 3: Cogentix Medical Inc. (Nasdaq: CGNT)

    Based in Minnesota, Cogentix Medical Inc. (Nasdaq: CGNT) makes fiber optic and video endoscopy products for medical use. Endoscopy products allow medical professionals to look inside the body. The company’s stock currently trades at $3.07.

investment advisor: Ducommun Incorporated(DCO)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

investment advisor: Revlon, Inc.(REV)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    Shares of Revlon, Inc.(NYSE:REV) surged last month after the company announced a restructuring plan. According to data from S&P Global Market Intelligence, the stock gained 15%. The bulk of the increase came in the middle of the month when the restructuring plan was announced.

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

investment advisor: Alon USA Energy, Inc.(ALJ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, energy shares dipped by 0.70 percent. Meanwhile, top losers in the sector included TravelCenters of America LLC (NYSE: TA), down 18 percent, and Alon USA Energy, Inc. (NYSE: ALJ), down 8 percent.

  • [By Tom Dorsey]

    Over a several day period, I submitted questions and Mr. Eisman, President, Chief Executive Officer and Director of Alon USA Energy Inc. (ALJ) and the parent company of Alon USA Partners LP Inc. (ALDW) responded. He provided some key insights to some challenges the company faces, where the company is going, and the opportunities available in the future. This insight should provide investors with additional information to understand the value of the company and the opportunity as an investor in the company.

  • [By Manikandan Raman]

    Additionally, Cheng also downgraded Delek US Holdings, Inc. (NYSE: DK) to Equal Weight from Overweight, while upgrading Alon USA Energy, Inc. (NYSE: ALJ) to Equal Weight from Underweight.

investment advisor: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

investment advisor: Cardtronics, Inc.(CATM)

Advisors’ Opinion:

  • [By Timothy Green]

    Non-bank ATM operator Cardtronics (NASDAQ:CATM) slumped on Friday despite reporting fourth-quarter results that beat analyst estimates on all fronts. The culprit driving the decline may be the company’s 2017 guidance, which calls for a decline in adjusted EPS. At 2:30 p.m. EST, the stock was down about 10%.

Leave a Reply

Your email address will not be published.